Bal Pharma

BALPHARMA

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌

‌

‌
‌
‌
‌
‌
‌
‌

‌
‌
‌
‌
‌
‌

Bal Pharma Stock Price - ₹95.75 | Healthcare | askfuzz

Bal Pharma

BALPHARMA

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

Announcements

Exchange filings, newest first

24 Sept
7 Sept
26 Aug

Documents by quarter

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

4 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

214 pages

Annual Reports 2024-25

189 pages

Annual Reports 2023-24

191 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

25 Sept 2026Bal Pharma Ltd submits voting results and scrutinizer's report for 39th AGM held on 24 Sep 2026Record Date

25 Sept 2026Bal Pharma Ltd approves change in designation of Mr. Ravindra Kumar Kothari to Executive Director and Mr. Virupakshaya Himesh to Non-Executive DirectorKMP

24 Sept 2026Bal Pharma Ltd outcome of 39th AGM held on 24 Sep 2026 via VC; business transacted as per noticeRecord Date

7 Sept 2026Bal Pharma Ltd announces allotment of 10,00,000 warrants on preferential basis to promoter at ₹84 per warrant on 07 Sep 2026Capital Raise

27 Aug 2026Bal Pharma Ltd declares final dividend of ₹1.20 per share; record date 17 Sep 2026Record Date

26 Aug 2026Bal Pharma Ltd AGM scheduled on 24 Sep 2026Record Date

25 Aug 2026Bal Pharma Ltd clarifies on 25 Aug 2026 that tentative timeline for utilization of net proceeds from preferential issue of convertible warrants is 18 months from allotment.Capital Raise